Pharma-Bio Serv, Inc.
PBSV
$0.55
$0.07515.79%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 105.21% | -44.62% | 21.02% | -474.73% | -108.95% |
| Total Depreciation and Amortization | 4.73% | -0.67% | -1.97% | 1.56% | -6.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 166.10% | -426.13% | 93.37% | -18.39% | -610.55% |
| Change in Net Operating Assets | 93.43% | 33.29% | -146.54% | 147.46% | 12.38% |
| Cash from Operations | 111.70% | 4.34% | -196.53% | 135.38% | -67.77% |
| Capital Expenditure | -8,163.16% | -- | -- | -150.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -91.10% | 904.49% | 90.36% | -165.01% | 218.61% |
| Cash from Investing | -95.35% | 904.07% | 90.37% | -165.01% | 218.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | 26.09% | 68.06% | -800.00% | 84.31% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | 99.90% | -23,852.78% | -800.00% | 84.31% |
| Foreign Exchange rate Adjustments | 60.56% | 64.32% | -264.46% | 120.79% | -2,228.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -91.79% | 203.67% | 27.98% | -153.22% | 244.95% |
